How Bristol-Myers Squibb Company (BMY) Delivers Strong Yields Even in Tough Markets

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best Recession Proof Dividend Stocks to Buy.

Bristol-Myers Squibb Company (NYSE:BMY) is an American multinational pharmaceutical company. It concentrates primarily on branded pharmaceuticals, a sector known for high entry barriers and strong profitability. Developing breakthrough drugs requires billions in investment and years of research, with relatively few candidates making it to market.

However, those that succeed can deliver billions in revenue, supported by long-lasting patent protection that shields them from competition. Because medications remain essential regardless of economic conditions, they are considered recession-resistant. This resilience helped Bristol-Myers Squibb Company (NYSE:BMY)’s stock decline only 32% during the 2007–09 financial crisis, compared with a drop of more than 50% for the broader market.

Bristol-Myers Squibb Company (NYSE:BMY) is also a strong dividend company. Currently, it pays a quarterly dividend of $0.62 per share and has a dividend yield of 5.62%, as of September 26. The company has raised its payouts for 16 years in a row.

While we acknowledge the potential of BMY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Best Telecom Dividend Stocks to Buy for 2025 and 11 Best Bank Dividend Stocks to Buy.

Disclosure: None.